Variable Square Pulse Erbium Promising for Stretch Marks

This article originally appeared here.
Share this content:
Variable Square Pulse Erbium Promising for Stretch Marks
Variable Square Pulse Erbium Promising for Stretch Marks

WEDNESDAY, Aug. 16, 2017 (HealthDay News) -- Resurfacing with a variable square pulse Erbium: YAG (VSP Er:YAG) laser is a promising treatment option for stretch marks, according to a small study published online Aug. 9 in the Journal of Cosmetic Dermatology.

Rungsima Wanitphakdeedecha, M.D., from Mahidol University in Bangkok, and colleagues evaluated VSP Er:YA laser for the treatment of striae in skin phototypes III-IV among 21 women treated monthly for two months. Treatment consisted of one side being treated with one pass of 400 mJ in short pulse (SP) mode with 50 percent overlapping and one pass of 2.2 J/cm2 in smooth (SM) mode with nonoverlapping. The other side was treated with two passes of 400 mJ in SP mode with 50 percent overlapping.

The researchers found that in both the SP-and-SM and SP-only groups, volume of striae distensae measured by Visioscan VC98 was reduced significantly at six-month follow-up. Skin roughness, skin smoothness, and surface measured by Visioscan VC98 did not differ between the groups. The most common side effect was transient postinflammatory hyperpigmentation (PIH), which could last six months, in patients with darker skin tone and even in nonsun-exposure areas.

"Lower fluence should be used in patients with darker skin phototype to avoid the risk of PIH," conclude the authors.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »